Skip to main content
Clinical Trials/TCTR20220316003
TCTR20220316003
Recruiting
Phase 1

Changes of the temporomandibular joint in class III camouflage treatment: CBCT and MRI analysis

Faculty of Dentistry, Khon Kaen University0 sites7 target enrollmentMarch 16, 2022

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Skeletal class III malocclusion in non-growing patients
Sponsor
Faculty of Dentistry, Khon Kaen University
Enrollment
7
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 16, 2022
End Date
February 28, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Faculty of Dentistry, Khon Kaen University

Eligibility Criteria

Inclusion Criteria

  • (Camouflage group) 1\. Mild\-moderate skeletal class III malocclusion, with CO\-CR discrepancy, 2\. 18 years of age or above, with complete mandibular growth (CS6\), 3\. ASA I with healthy general appearance, 4\. Willing to receive camouflage treatment
  • (Surgical group) 1\. Skeletal class III malocclusion, treated with bilateral sagittal split ramus osteotomy (BSSRO) completed in 2019\-2021, 2\. 18 years of age or above, with complete mandibular growth (CS6\), 3\. ASA I with healthy general appearance

Exclusion Criteria

  • (Camouflage group) 1\. Do not agree to participate and co\-operate until the end of the study, 2\. Presenting signs and symptoms of TMD, 3\. Severe dentofacial deformities, 4\. Being diagnosed with psychiatric illness, 5\. Planning to get pregnant between 2021\-2024, 6\. Unable to undergo MRI such as claustrophobia, and having fixed/implanted metal prostheses (can not be removed before MRI)
  • (Surgical group) 1\. Do not agree to participate and co\-operate until the end of the study, 2\. Presenting signs and symptoms of TMD, 3\. Severe congenital deformities in craniofacial region (e.g. cleft lip and palate), 4\. Having history of major surgery in craniofacial region (for other purposes which were not to correct skeletal class III), 5\. Being diagnosed with psychiatric illness

Outcomes

Primary Outcomes

Not specified

Similar Trials